ADCT Financials
Adc Therapeutics Sa - Financial statements & key metrics
Stock Price
$4.11
Market Cap
$509.13M
EPS
$-1.38
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$70.84M
Gross Profit
-
Operating Income
-
Net Income
$-157.85M
EPS (Diluted)
$-1.62
Balance Sheet Highlights
Total Assets
$321.98M
Total Liabilities
$524.62M
Shareholders Equity
-
Cash & Equivalents
$250.87M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-123.83M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-57.4%
Operating Margin
-1.9%
Net Margin
-2.2%
ROE
-7.1%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is ADCT revenue?
ADCT's most recent quarterly revenue was $70.84M. Annual revenue can be calculated by summing the four most recent quarters.
Is ADCT profitable?
ADCT reported a loss of $157.85M in the most recent quarter. The net profit margin is -2.2%.
What is ADCT market cap?
ADCT has a market capitalization of $509.13M, making it a small-cap stock.
Does ADCT have debt?
View ADCT's balance sheet for debt information.
What is ADCT cash flow?
Cash flow data is available in the full financial statements.